Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Human Papilloma Virus (HPV): later-stage trial registry
3 of 4 indexed Human Papilloma Virus (HPV) trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Human Papilloma Virus (HPV): 4 US clinical trials tracked, 3 recruiting.
Human Papilloma Virus (HPV) is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Verrica Pharmaceuticals, running 1 of these trials.
Enrollment posture brief
Registry condition human-papilloma-virus-hpv
OPEN 3 | RECR 75% | LATE 1 | EARLY 0 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)
Human Papilloma Virus (HPV) lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Human Papilloma Virus (HPV) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Human Papilloma Virus (HPV) is recruiting above its size-band peers.
3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Unidos Contra el VPH
University of Texas at Austin
NCT06825689
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)
Verrica Pharmaceuticals
NCT07246590
Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy
University of Florida
NCT07214584
New Strategies to Assess Anal Cancer Risk In Women
Emory University
NCT02873741
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Human Papilloma Virus (HPV) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Human Papilloma Virus (HPV) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Human Papilloma Virus (HPV) page
4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Human Papilloma Virus (HPV) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Verrica Pharmaceuticals sponsors the most Human Papilloma Virus (HPV) trials on record, review their full trial history before evaluating a specific study. See Verrica Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Human Papilloma Virus (HPV) condition card totals 4 registered trials; most-linked intervention High Resolution Anoscopy (HRA); top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.